C2i Genomics and Gustave Roussy Collaborate to Demonstrate Utility of ctDNA-guided Immunotherapy in Early-Stage Solid Tumors
C2i Genomics and Gustave Roussy Collaborate to Demonstrate Utility of ctDNA-guided Immunotherapy in Early-Stage Solid Tumors
October 18, 2023